Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Aconitum kusnezoffii
Aconite sauvage de MTCh pour les conditions de douleur sévère.
Cao Wu (Aconitum kusnezoffii) is a processed wild aconite root used in Traditional Chinese Medicine for severe pain conditions, particularly arthritis and cold bi syndrome. Its primary active compounds include aconitine, mesaconitine, and deoxyaconitine, which provide potent analgesic, anti-rheumatic, and local anesthetic effects, but require careful processing to mitigate extreme toxicity.
Aconitine derivatives bind to voltage-gated sodium channels (Nav1.7, Nav1.8) with high affinity, causing persistent channel activation and prolonged depolarization, which blocks pain signal transmission at low doses. Additionally, these compounds inhibit NF-κB signaling and reduce pro-inflammatory cytokines (TNF-α, IL-6), contributing to anti-rheumatic effects. The narrow therapeutic window and cardiotoxicity arise from off-target effects on cardiac sodium channels (Nav1.5), leading to arrhythmias.
Aconite sauvage de MTCh pour les conditions de douleur sévère.
Cao Wu (Aconitum kusnezoffii) is a processed wild aconite root used in Traditional Chinese Medicine for severe pain conditions, particularly arthritis and cold bi syndrome. Its primary active compounds include aconitine, mesaconitine, and deoxyaconitine, which provide potent analgesic, anti-rheumatic, and local anesthetic effects, but require careful processing to mitigate extreme toxicity.
Aconitine derivatives bind to voltage-gated sodium channels (Nav1.7, Nav1.8) with high affinity, causing persistent channel activation and prolonged depolarization, which blocks pain signal transmission at low doses. Additionally, these compounds inhibit NF-κB signaling and reduce pro-inflammatory cytokines (TNF-α, IL-6), contributing to anti-rheumatic effects. The narrow therapeutic window and cardiotoxicity arise from off-target effects on cardiac sodium channels (Nav1.5), leading to arrhythmias.